definiens: ), although remain being Know How, as defined below, licensor vis -à - vis the Commercial Supplier and Application Know How, as defined below, licen sor vis -à - vis Evaxion ; Page 3 of 50 Execution Copy ( G ) The Parties acknowledge that SSI ’s contracting of a Commercial Supplier, including the associated Licensed Adjuvant manufacturing technology transfer from SSI to the Commercial Supplier, may be time consuming, implying that the Parties have agreed for SSI to supply to Evaxion a certain stock of Licensed Adjuvant manufactured or to be manufactured by the Interim Supplier for Evaxion Vaccine development use ; and, ( H ) Were SSI to fail impleme nting the Preferred Model, i.e. to fail closing an agreement with a Commercial Supplier as per Recital F above, and only in case of such failure, SSI shall, to protect Evaxion ’s and its Sub - licensees ’ interest in receiving the required amounts of Licensed Adjuvant also beyond the development phase, irrespectively of such failure, grant a license, including Licensed Adjuvant technology transfer assistance, to Evaxion and its Sub -licensees, ( the ), enabling Evaxion to appoint a Licensed Adjuvant manufacturing CMO in lieu of the Commercial Supplier never appointed by SSI, which replacement CMO may then cover Evaxion ’s and its Sub -licensees Licensed Adjuvant needs by carrying out manufacturing activities on basis of Know How vested in and C ontrolled by SSI and in turn licensed to Evaxion on a non -exclusive basis